August 3, 2015 SOURCE: REGEN BIOPHARMA INC.
Entest BioMedical Inc.’s Zander Therapeutics Unit: Initial Focus is Small Molecule and Cancer Stem Targeting for Veterinary Oncology
July 21, 2015 SOURCE: REGEN BIOPHARMA INC.
Regen BioPharma, Inc. Successfully Completes in Life Portion of Experiments Requested by FDA for HemaXellerate Pre-Clinical Study
July 14, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Presents Preclinical Proof-of- Concept of DiffronC Effectiveness at the International Society for Stem Cell Research (ISSCR) Annual Meeting
July 9, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Reports Successful Dosing of HemaXellerate in FDA-Requested GLP Animal Study
June 16, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Announces Presentation at the International Society for Stem Cell Research 13th Annual Meeting in Stockholm, Sweden
June 12, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Receives Notice of Allowance for U.S. Patent for Screening of Small Molecules Against Its Nuclear Receptor Target
June 10, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Cancer Clinical Trials Expert Dr. Santosh Kesari to Assist Regen BioPharma, Inc. in Addressing FDA Questions Regarding Planned dCellVax Immunotherapy Clinical Trial for Breast Cancer
June 04, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Recruits Retinoid Experts Dr. Hinrich Gronemeyer, Dr. William S. Blaner, and Dr. Louise Purton to Serve on Scientific Advisory Board
May 27, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Files Patent Application on mRNA Dendritic Cell Cancer Immunotherapeutic
May 05, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Makes Three Presentations at the 13th International Symposium on Myelodysplastic Syndromes Held April 29 to May 2, 2015 in Washington, DC